Kristiina Vuori, M.D., Ph.D.

Sanford Burnham Prebys Medical Discovery Institute
email: kvuori@burnham.org

Grants

Breast Cancer Studies in a 3-D Cell Culture System 2005 (Cycle 11)
IDEA (Innovative, Developmental, and Exploratory Awards) 11IB-0132 $188,602
Overcoming Tamoxifen-resistance in Breast Cancer 2003 (Cycle IX)
STEP Award 9WB-0055 $281,370
Overcoming Drug Resistance in Breast Cancer 2001 (Cycle VII)
STEP Award 7WB-0008 $378,529
Cell Adhesion and Drug Resistance in Breast Cancer 2000 (Cycle VI)
IDEAS II 6JB-0017 $190,773
How Does Endostatin Inhibit Breast Cancer Angiogenesis? 1999 (Cycle V)
IDEAS II 5JB-0020 $292,535


SHEP1 function in cell migration is impaired by a single amino acid mutation that disrupts association with the scaffolding protein cas but not with Ras GTPases.
  Periodical: Journal of Biological Chemistry
  Author(s): M Dail, M Kalo, Jaime A. Seddon, Jean-François Côté,Kristiina Vuori, E Pasquale
  Yr: 2004 Vol: 279 Nbr: Pgs: 41892-41902
  Associated Grant: Overcoming Tamoxifen-resistance in Breast Cancer
 
p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration.
  Periodical: Journal of Biological Chemistry
  Author(s): Yama A. Abassi, Marko Rehn Niklas Ekman Kari Alitalo and Kristiina Vuori
  Yr: 2003 Vol: 278 Nbr: 37 Pgs: 35363-35643
  Associated Grant: Overcoming Tamoxifen-resistance in Breast Cancer
 
Interaction of Endostatin with Integrins Implicated in Angiogenesis
  Periodical: Proceedings of the National Academy of Sciences of the United States of America
  Author(s): Reh, M, Veikkola T, et al, and Vuori K
  Yr: 2001 Vol: 98 Nbr: 3 Pgs: 1024-1029
  Associated Grant: How Does Endostatin Inhibit Breast Cancer Angiogenesis?
 
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells.
  Periodical: Oncogene
  Author(s): Aoudjit F, Vuori K.
  Yr: 2001 Vol: 20 Nbr: 36 Pgs: 4995-5004
  Associated Grant: Overcoming Drug Resistance in Breast Cancer